A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.


We propose a design strategy for single-arm clinical trials in which the goals are to find a dose of an experimental treatment satisfying both safety and efficacy requirements, treat a sufficiently large number of patients to estimate the rates of these events at the selected dose with a given reliability, and stop the trial early if it is likely that no… (More)